Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX

View source ↗

Summary

A completed clinical trial comparing outcomes of rheumatoid arthritis patients starting Xeljanz with oral methotrexate who withdraw MTX versus those who continu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2019-10-22